Novolog Mix 70/30 Injection, Suspension
Product Images NDC 0169-2201

Product Visual Gallery

This gallery contains 51 technical images submitted to the FDA as part of the official labeling for Novolog Mix 70/30 (NDC 0169-2201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novo Nordisk Pharmaceutical Industries, Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Export 00

NovoLog Mix 70/30 FlexPen Prefilled Syringe label for insulin aspart 100 units/mL injection suspension. The carton shows a 5 x 3 mL package, indicated for subcutaneous use and single patient use only. It includes a visual of the blue FlexPen injector and specifies dispensing only in the sealed carton by prescription. Labeler is Novo Nordisk Pharmaceutical Industries, LP.*

FDA Label Image

Export 01

Packaging label for NovoLog Mix 70/30 FlexPen Prefilled Syringe containing insulin aspart 100 units/mL (U-100) injection suspension. The label shows a blue pen device and syringe image with directions for single-patient use. Manufactured by Novo Nordisk Pharmaceutical Industries, LP, the label includes storage instructions, usage warnings, and manufacturer contact information. The packaging supports 5 x 3 mL prefilled insulin syringes.*

FDA Label Image

Export 02

Packaging label for NovoLog Mix 70/30 (insulin aspart protamine and insulin aspart) injection suspension, 100 units/mL. This is a 10 mL multiple-dose vial for subcutaneous use, labeled by Novo Nordisk Pharmaceutical Industries, LP. The label includes usage instructions, storage conditions, and manufacturer contact information.*

FDA Label Image

Export 03

Packaging label for NovoLog Mix 70/30 (insulin aspart protamine and insulin aspart) injectable suspension, 100 units/mL strength. The label indicates a 10 mL multi-dose vial intended for subcutaneous use, manufactured by Novo Nordisk Pharmaceutical Industries, LP. It includes storage instructions, dosing warnings, and a barcode.*

FDA Label Image

Export 04

A line graph showing mean serum insulin levels (mU/L) over 24 hours after dosing with NovoLog Mix 70/30. The x-axis represents time in hours, and the y-axis indicates mean serum insulin concentration. Data points show the mean values with standard error of the mean (SEM) bars.*

FDA Label Image

Export 05

A line graph showing the glucose infusion rate (mg/kg*min) over 24 hours for NovoLog Mix 70/30. The rate peaks sharply within the first few hours, reaching near 9 mg/kg*min, then gradually declines over the remainder of the 24-hour period.*

FDA Label Image

Molecular Chain Of Insulin Aspart. (Image 01)

Chemical structure diagram showing the amino acid sequences of the A-chain and B-chain of insulin aspart, indicating disulfide bonds and the specific arrangement of amino acids in both chains.*

FDA Label Image

Flexpen Drawing (Image 04)

An exploded diagram of the NovoLog Mix 70/30 FlexPen showing its components from left to right: pen cap, rubber stopper, 12 glass units, ball, cartridge, cartridge scale, pointer, dose selector, and push-button. The diagram illustrates the FlexPen's assembly and dosing features for insulin aspart injection suspension.*

FDA Label Image

Figure D (Image 05)

Illustration showing needle components for three types of insulin needles: NovoFine, NovoFine Plus, and NovoTwist. Each type is displayed with individual parts labeled as big outer needle cap, inner needle cap, needle, and protective tab, illustrating their assembly or separation.*

FDA Label Image

Figure F (Image 06)

Instructional illustration showing use steps for NovoFine and NovoFine Plus needles with NovoTwist. The left panel depicts attaching a needle to a pen by pushing the needle onto the pen. The right panel shows twisting the NovoTwist needle to secure it in place.*

FDA Label Image

Image 09

An illustration showing front and back views of a human torso highlighting common subcutaneous injection sites in the abdomen and upper buttocks. This figure likely relates to proper administration areas for subcutaneous injections.*

FDA Label Image

Image 10

FDA Label Image

Image 11

FDA Label Image

Image 12

FDA Label Image

Image 13

FDA Label Image

Image 14

FDA Label Image

Image 15

FDA Label Image

Image 16

FDA Label Image

Image 17

FDA Label Image

Image 18

FDA Label Image

Image 19

FDA Label Image

Image 20

FDA Label Image

Image 21

FDA Label Image

Image 22

FDA Label Image

Image 23

FDA Label Image

Image 24

FDA Label Image

Image 25

An instructional illustration showing the connection of syringe components labeled 'NovoFine' or 'NovoFine Plus' on the left and 'NovoTwist' on the right. The images depict hand placement and attachment method for these injection needles or syringe parts used with insulin administration.*

FDA Label Image

Image 26

An instructional illustration showing two steps of preparing a NovoLog Mix 70/30 insulin injection using NovoFine or NovoFine Plus and NovoTwist needles. It depicts how to attach or prepare the needle on the syringe prior to administration.*

FDA Label Image

Vial Figure (Image 35)

An instructional illustration showing a vial with labeled parts, including a tamper resistant cap on top and a rubber stopper under the cap. The vial is intended for containing injectable suspension medication.*

FDA Label Image

Hand & Vial Figure (Image 36)

An instructional illustration showing a hand holding a small vial, demonstrating how to grip the vial, likely for injection of NovoLog Mix 70/30 insulin aspart suspension.*

FDA Label Image

Figure A & Figure B (Image 37)

An instructional illustration showing two hand positions opening a vial cap labeled as Figure A and Figure B. The images demonstrate how to remove the cap from a vial, likely related to the preparation of an injectable medication such as NovoLog Mix 70/30 insulin aspart suspension.*

FDA Label Image

Figure C (Image 38)

An instructional illustration showing the proper technique for holding a hand, with an arrow indicating a side-to-side motion. This figure likely demonstrates part of a method related to injection or medication administration.*

FDA Label Image

Figure D (Image 39)

Instructional illustration labeled as Figure D showing a hand holding a syringe above a vial with an arrow pointing downward, demonstrating the step of inserting the syringe needle into the vial for drawing medication.*

FDA Label Image

Figure E (Image 40)

An instructional illustration labeled Figure E, showing two hands preparing a syringe by drawing liquid medication from a vial into the syringe piston, demonstrating part of the injection preparation process.*

FDA Label Image

Figure F (Image 41)

An instructional illustration labeled as Figure F showing a hand holding a syringe and a vial, demonstrating how to draw medication from the vial with a downward arrow indicating the syringe plunger being pulled back.*

FDA Label Image

Figure G (Image 42)

Illustration showing a hand holding a vial of medication above a syringe with an arrow indicating the movement of the vial downward into the syringe, demonstrating how to draw insulin aspart suspension for subcutaneous injection.*

FDA Label Image

Figure H (Image 43)

An instructional illustration showing a person preparing an injection by drawing liquid from a vial into a syringe. The figure is labeled as Figure H and depicts the proper technique for filling the syringe from a vial for subcutaneous injection.*

FDA Label Image

Figure I (Image 44)

Instructional illustration showing a hand drawing NovoLog Mix 70/30 injection suspension from a vial into a syringe. The image depicts the vial being held upside down and the syringe needle inserted into the vial to withdraw the medication.*

FDA Label Image

Figure J (Image 45)

An illustration showing a hand holding a vial and a syringe with an arrow indicating to draw liquid from the vial into the syringe, demonstrating part of the injection preparation process.*

FDA Label Image

Figure L (Image 47)

An instructional illustration showing hands preparing a syringe for injection. One hand holds the syringe while the other hand places a cap or needle onto the syringe, indicated by a downward arrow. No text or branding visible.*

FDA Label Image

Figure M (Image 48)

An instructional illustration labeled as Figure M showing a person preparing to administer a subcutaneous injection using a syringe into the forearm. The image depicts the correct hand position and angle for injection.*

FDA Label Image

Pull Off The Pen Cap. (Image 50)

An instructional illustration demonstrating the method to prepare or use a syringe for injection, showing fingers holding the syringe and an arrow indicating the direction for attaching or adjusting the needle or cap.*

FDA Label Image

Roll The Pen Between Your Palms. (Image 51)

An instructional illustration showing a person's hand holding a syringe and rotating the insulin vial by rolling it gently between the palms, indicating mixing the insulin suspension before injection.*

FDA Label Image

Move The Pen Up And Down. (Image 52)

Illustration showing a two-step process to prepare an injectable suspension. Step 1 depicts holding a vial upright, and Step 2 shows inverting or turning the vial downward. The image likely demonstrates mixing the insulin suspension before injection.*

FDA Label Image

Turn The Dose Selector To 2 Units. (Image 56)

An instructional illustration depicting a hand adjusting an insulin pen dial to select a dose of 2 units. The pen is labeled with dosing indicators, showing the selection of 2 units for injection.*

FDA Label Image

Tap The Needle. (Image 57)

An instructional illustration showing a close-up of a finger pressing the plunger of a syringe with a liquid injection suspension, with signal lines indicating activation or injection in progress.*

FDA Label Image

Press The Push-button. (Image 58)

An instructional illustration showing a hand holding a NovoLog Mix 70/30 injection pen. The image demonstrates pulling off the pen cap by lifting it upwards with an arrow indicating motion, and a small inset shows the proper removal of the cap from the pen.*

FDA Label Image

Select Your Dose. (Image 59)

An instructional illustration showing a hand dialing a dose on an insulin pen. The pen window displays selections of 5 units and 24 units, demonstrating how to select the insulin dose.*

FDA Label Image

Press The Push Button To Inject. (Image 60)

Instructional illustration showing how to prepare a NovoLog Mix 70/30 insulin injection. It depicts a hand holding the vial and a syringe, with an arrow indicating to invert or mix the vial before use to ensure proper suspension.*

FDA Label Image

Keep The Needle In The Skin For At Least 6 Seconds. (Image 61)

An instructional illustration showing the injection technique for NovoLog Mix 70/30 (insulin aspart) 100 units/mL suspension. The image depicts a pen injector needle about to be inserted at a shallow angle into the skin, indicating the subcutaneous administration route.*

FDA Label Image

Replace The Pen Cap. (Image 62)

An instructional illustration showing a close-up of a person holding a NovoLog Mix 70/30 injection pen. The image demonstrates how to unlock or prepare the injection pen by rotating or pressing a blue part of the device, indicated by arrows.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.